AT282060B - Verfahren zur Herstellung von Penicillin-Präparaten - Google Patents

Verfahren zur Herstellung von Penicillin-Präparaten

Info

Publication number
AT282060B
AT282060B AT835168A AT835168A AT282060B AT 282060 B AT282060 B AT 282060B AT 835168 A AT835168 A AT 835168A AT 835168 A AT835168 A AT 835168A AT 282060 B AT282060 B AT 282060B
Authority
AT
Austria
Prior art keywords
manufacture
penicillin preparations
penicillin
preparations
Prior art date
Application number
AT835168A
Other languages
English (en)
Inventor
Alphonse Peter Granatek
Michael Paul Demurio
Bernard Charles Nunning
Nicholas George Athanas
Robert Lewis Dana
Edmund Stanley Granatek
Raymond George Daoust
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Application granted granted Critical
Publication of AT282060B publication Critical patent/AT282060B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT835168A 1964-05-20 1968-08-28 Verfahren zur Herstellung von Penicillin-Präparaten AT282060B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36899164A 1964-05-20 1964-05-20
US66529767A 1967-09-05 1967-09-05

Publications (1)

Publication Number Publication Date
AT282060B true AT282060B (de) 1970-06-10

Family

ID=31949833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT835168A AT282060B (de) 1964-05-20 1968-08-28 Verfahren zur Herstellung von Penicillin-Präparaten

Country Status (4)

Country Link
US (1) US3459858A (de)
AT (1) AT282060B (de)
GB (2) GB1113492A (de)
SU (1) SU380002A3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692896A (en) * 1968-06-14 1972-09-19 Isumura Juntendo Co Ltd Process for the preparation of water-soluble tablets
DE2347713C3 (de) * 1972-09-25 1980-03-06 Warner-Lambert Co., Morris Plains, N.J. (V.St.A.) Acetylsalicylsäurekautablette
AU607784B2 (en) * 1987-05-27 1991-03-14 Akzo N.V. Dry, rapidly soluble, compositions of beta-lactam antibiotics
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US7485319B2 (en) * 2003-07-25 2009-02-03 Warner Chilcott Company, Inc. Doxycycline metal complex in a solid dosage form
WO2006105615A1 (en) 2005-04-08 2006-10-12 Ozpharma Pty Ltd Buccal delivery system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) * 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets

Also Published As

Publication number Publication date
GB1113492A (en) 1968-05-15
US3459858A (en) 1969-08-05
GB1248189A (en) 1971-09-29
SU380002A3 (de) 1973-04-20

Similar Documents

Publication Publication Date Title
CH459982A (de) Verfahren zur Herstellung von Polyenketonen
CH448057A (de) Verfahren zur Herstellung von Phenylalkylaminoguanidinen
CH478779A (de) Verfahren zur Herstellung von a-Dithiosemicarbazonen
CH472353A (de) Verfahren zur Herstellung von Pyridin-4-thiolen
CH467268A (de) Verfahren zur Herstellung von 5-Nitroimidazolen
AT282060B (de) Verfahren zur Herstellung von Penicillin-Präparaten
CH440294A (de) Verfahren zur Herstellung von 4-Nitropyrazolen
CH478790A (de) Verfahren zur Herstellung von 7-Aminocumarinen
CH443528A (de) Verfahren zur Herstellung von 4-Brom-3-hydroxychinophthalon
CH447170A (de) Verfahren zur Herstellung von N-Alkyl-a-pyrrolidonen
CH473086A (de) Verfahren zur Herstellung von Acetylenaminen
CH473761A (de) Verfahren zur Herstellung von Dibenzocycloheptenylaminen
CH461473A (de) Verfahren zur Herstellung von Dibenzocycloheptenylaminen
CH478833A (de) Verfahren zur Herstellung von Pyrimidopyrimidothiazinen
CH478830A (de) Verfahren zur Herstellung von 3-Halogen-Thiadiazolen
CH475262A (de) Verfahren zur Herstellung von Pyrazin-4-oxyden
CH442336A (de) Verfahren zur Herstellung von o-Amino-benzonitrilen
CH479554A (de) Verfahren zur Herstellung von 3-Hydroxynitrilen
CH471112A (de) Verfahren zur Herstellung von 4- Vinylchroman-4-olen
CH465639A (de) Verfahren zur Herstellung von L-a-Niederalkyl-hydroxyphenylalaninen
CH453380A (de) Verfahren zur Herstellung von L-Tryptophanyl-L-methionyl-L-asparagyl-L-phenylalanimanid
CH460754A (de) Verfahren zur Herstellung von a-Acetyldigitoxin
CH450411A (de) Verfahren zur Herstellung von 6a-Methyl-16-fluor-methylen-steroiden
CH443290A (de) Verfahren zur Herstellung von 17a-Äthoxy-6-chlor-6-dehydro-progesteron
CH450432A (de) Verfahren zur Herstellung von Bisaziridinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee